Physics of Nuclear Medicine: Recent Advances edited by D. V. Rao, R. Chandra, and M. C. Graham

Autor: Anthony R. Benedetto

Publikováno v: Medical Physics. 12:116-116

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ceebdd5f257883d5b542ee59c4db3104
https://doi.org/10.1118/1.595726

Development of an ombrotrophic peat bog (low ash) reference material for the determination of elemental concentrations

Autor: C. Yafa, J. G. Farmer, M. C. Graham, J. R. Bacon, C. Barbante, W. R. L. Cairns, R. Bindler, I. Renberg, A. Cheburkin, H. Emons, M. J. Handley, S. A. Norton, M. Krachler, W. Shotyk, X. D. Li, A. Martinez-Cortizas, I. D. Pulford, V. MacIver, J. Schweyer

Publikováno v: Journal of environmental monitoring
6 (2004): 493–501.
info:cnr-pdr/source/autori:C. Yafa, J. G. Farmer, M. C. Graham, J. R. Bacon, C. Barbante, W. R. L. Cairns, R. Bindler, I. Renberg, A. Cheburkin, H. Emons, M. J. Handley, S. A. Norton, M. Krachler, W. Shotyk, X. D. Li, A. Martinez-Cortizas, I. D. Pulford, V. MacIver, J. Schweyer, E./titolo:Development of an ombrotrophic peat bog (low ash) reference material for the determination of elemental concentrations./doi:/rivista:Journal of environmental monitoring (Print)/anno:2004/pagina_da:493/pagina_a:501/intervallo_pagine:493–501/volume:6

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::47f20a9213a602397f86d2350d1904a1
http://www.cnr.it/prodotto/i/20016

1-苯基-5-氨基吡唑类蜕皮激素类似物的合成与杀虫活性.

Autor: 李秀珍¹ lxzhen@cau.edu.cn, 靳彬艳¹, 崔佳琳¹, 冯彦姣¹, 张晓鸣¹, 张 莉¹ zhang_li@cau.edu.cn

Publikováno v: Chinese Journal of Pesticide Science / Nongyaoxue Xuebao. Jun2024, Vol. 26 Issue 3, p451-461. 11p.

Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancer

Autor: M C, Graham, H I, Scher, G B, Liu, S D, Yeh, T, Curley, F, Daghighian, S J, Goldsmith, S M, Larson

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 5(6)

Rhenium-186 (tin)-labeled hydroxyethylidene diphosphonate (186Re-labeled HEDP) was evaluated in 27 men with progressive androgen-independent prostate cancer and bone metastases. Administered activities ranged from 1251 to 4336 MBq (33.8-117.2 mCi). T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bea91328763a1dffb5d66c792a9d77eb
https://pubmed.ncbi.nlm.nih.gov/10389913

Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma

Autor: C R, Divgi, N H, Bander, A M, Scott, J A, O'Donoghue, G, Sgouros, S, Welt, R D, Finn, F, Morrissey, P, Capitelli, J M, Williams, D, Deland, A, Nakhre, E, Oosterwijk, S, Gulec, M C, Graham, S M, Larson, L J, Old

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 4(11)

This Phase I/II radioimmunotherapy study was carried out to determine the maximum tolerated dose (MTD) and therapeutic potential of 131I-G250. Thirty-three patients with measurable metastatic renal cell carcinoma were treated. Groups of at least thre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9ddd0f615fa6e34d12d5a10e0099f98d
https://pubmed.ncbi.nlm.nih.gov/9829736